Exploring Potential Multi-Target Inhibition Mechanisms of Ganoderma lucidum Against EBV-Mediated DLBCL Using Integrative Bioinformatics, Machine Learning, and Network Pharmacology Approaches.
Epstein-Barr virus (EBV)-associated diffuse large B-cell lymphoma (DLBCL) represents a significant clinical challenge with limited targeted therapeutic options. Despite the known antiviral and anticancer properties of Ganoderma lucidum, its specific molecular mechanisms against EBV-mediated DLBCL remain unexplored. The...